Premium
Telemedicine approach for psoriasis management, time for application? A systematic review of published studies
Author(s) -
Dahy Abdullah,
ElQushayri Amr Ehab,
Mahmoud Abdalla Reda,
Alkelany Tareq Adel,
Salman Samar
Publication year - 2020
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.13908
Subject(s) - medicine , teledermatology , telemedicine , psoriasis , randomized controlled trial , medline , covid-19 , pandemic , intensive care medicine , dermatology , health care , surgery , disease , political science , law , economics , economic growth , infectious disease (medical specialty)
Abstract Psoriasis is a common chronic inflammatory skin condition. It has a chronic course with multiple evolving relapses and patients require long‐term treatment and follow‐up. Teledermatology was introduced for diagnosis, treatment and follow‐up of chronic diseases. Thus, we performed a systematic review for collecting the evidence regarding the efficacy of telemedicine in psoriasis management. Out of 287 records, we included seven studies (four of which were randomized controlled trials). We found that telemedicine alone or combined with usual care had the same or higher efficacy of psoriasis management compared to usual care or control group. We recommend further studies for assessing the pros and cons of this intervention which can replace conventional strategies especially in pandemic times.